只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 3,057 | US$1.93 | US$5,900.01 | 15,492 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 2,531 | US$1.93 | US$4,884.83 | 21,729 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 3,277 | US$1.93 | US$6,324.61 | 16,689 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 2,106 | US$1.93 | US$4,064.58 | 13,113 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 2,436 | US$1.93 | US$4,701.48 | 14,394 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 2,118 | US$2.22 | US$4,701.96 | 11,958 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 1,831 | US$2.22 | US$4,064.82 | 11,007 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 2,465 | US$2.22 | US$5,472.30 | 12,435 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,654 | US$2.22 | US$5,891.88 | 13,412 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 2,067 | US$2.22 | US$4,588.74 | 19,198 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 1,829 | US$2.57 | US$4,700.53 | 9,840 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 1,582 | US$2.57 | US$4,065.74 | 9,176 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 2,129 | US$2.57 | US$5,471.53 | 9,970 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,292 | US$2.57 | US$5,890.44 | 10,758 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,786 | US$2.57 | US$4,590.02 | 17,131 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 1,984 | US$2.97 | US$5,892.48 | 8,466 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 1,583 | US$2.97 | US$4,701.51 | 8,011 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 1,369 | US$2.97 | US$4,065.93 | 7,594 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,545 | US$2.97 | US$4,588.65 | 15,345 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 1,843 | US$2.97 | US$5,473.71 | 7,841 | SEC |
| 2026-04-30 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Bigora Sian Officer · Chief Development Officer | 买入（P） | 1,971 | US$2.71 | US$5,341.41 | 7,481 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | Bigora Sian Officer · Chief Development Officer | 买入（P） | 1,986 | US$2.69 | US$5,342.34 | 7,496 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 1,748 | US$2.69 | US$4,702.12 | 6,441 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 1,511 | US$2.69 | US$4,064.59 | 6,236 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 2,034 | US$2.69 | US$5,471.46 | 6,013 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,190 | US$2.69 | US$5,891.10 | 6,498 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,706 | US$2.69 | US$4,589.14 | 13,813 | SEC |
| 2026-04-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 1,843 | US$2.97 | US$5,473.71 | 3,979 | SEC |
| 2026-04-15 2026-04-30 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 1,843 | US$2.97 | US$5,473.71 | 3,979 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 1,984 | US$2.97 | US$5,892.48 | 4,308 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | Bigora Sian Officer · Chief Development Officer | 买入（P） | 1,799 | US$2.97 | US$5,343.03 | 5,510 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 1,583 | US$2.97 | US$4,701.51 | 4,693 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 1,369 | US$2.97 | US$4,065.93 | 4,725 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 1,843 | US$2.97 | US$5,473.71 | 5,492 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,545 | US$2.97 | US$4,588.65 | 12,107 | SEC |
| 2026-03-31 2026-04-30 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 2,136 | US$2.54 | US$5,425.44 | 2,136 | SEC |
| 2026-03-31 2026-04-02 | PCSA Processa Pharmaceuticals, Inc. | Neal James R Director | 买入（P） | 789 | US$2.54 | US$2,004.06 | 818 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Baluch Khoso Director | 买入（P） | 2,269 | US$2.54 | US$5,763.26 | 2,325 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Bigora Sian Officer · Chief Development Officer | 买入（P） | 2,107 | US$2.54 | US$5,351.78 | 3,711 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 1,854 | US$2.54 | US$4,709.16 | 3,110 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 1,603 | US$2.54 | US$4,071.62 | 3,356 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 2,136 | US$2.54 | US$5,425.44 | 3,649 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Pannu Geraldine Director | 买入（P） | 2,072 | US$2.54 | US$5,262.88 | 2,188 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,324 | US$2.54 | US$5,902.96 | 2,324 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,810 | US$2.54 | US$4,597.40 | 10,562 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PCSA | 48,309 | 10 | 100,339.3805 | 48.15% | B, Q, N |